Authors :
Syahrir Supratman Hutabarat; Bastian Lubis; Dadik Wijaya
Volume/Issue :
Volume 7 - 2022, Issue 1 - January
Google Scholar :
http://bitly.ws/gu88
Scribd :
https://bit.ly/3KUQBW3
DOI :
https://doi.org/10.5281/zenodo.5913428
Abstract :
The high incidence of COVID-19, the
progressive nature of SARS-CoV-2 infection which can
cause acute respiratory distress syndrome that affects the
outcome of the disease, there is no effective management
guide for COVID-19 especially for oxygenation therapy,
and there is still controversy about use of high flow nasal
cannula in COVID-19 patients.
Methods: This study is an observational analytic study
with a retrospective cohort study design to assess the
ROX index on the success of using a high flow nasal
canule (HFNC) in COVID-19 patients treated at H Adam
Malik Hospital Medan based on data from medical
records of 70 people. This research was conducted in
October-November 2021 at RSUP H Adam Malik Medan
using data from April 2020-April 2021.
Results: In this study, the characteristics of the sample in
this study had a mean age of 47 years. Based on gender,
35 men were found to be the most and based on
comorbidities found in the most samples were DM and
hypertension, 9 people with a length of stay of 6 days. In
this study, the ROX index before the installation of
HFNC obtained an average of 3.12 and after the
installation of HFNC there was an increase in the average
ROX index of 4.48. In this study, the successful
installation of HFNC was 61 people out of a total of 70
samples.
Discussion: The ROX index can be helpful in identifying
subjects who are more at risk for poorer outcomes.
Therefore, early invasive mechanical ventilation can be
used to prevent worse outcomes in patients with COVID19-associated AHRF.
Keywords :
ROX index, high flow nasal canule, NIV, ventilator, COVID-19
The high incidence of COVID-19, the
progressive nature of SARS-CoV-2 infection which can
cause acute respiratory distress syndrome that affects the
outcome of the disease, there is no effective management
guide for COVID-19 especially for oxygenation therapy,
and there is still controversy about use of high flow nasal
cannula in COVID-19 patients.
Methods: This study is an observational analytic study
with a retrospective cohort study design to assess the
ROX index on the success of using a high flow nasal
canule (HFNC) in COVID-19 patients treated at H Adam
Malik Hospital Medan based on data from medical
records of 70 people. This research was conducted in
October-November 2021 at RSUP H Adam Malik Medan
using data from April 2020-April 2021.
Results: In this study, the characteristics of the sample in
this study had a mean age of 47 years. Based on gender,
35 men were found to be the most and based on
comorbidities found in the most samples were DM and
hypertension, 9 people with a length of stay of 6 days. In
this study, the ROX index before the installation of
HFNC obtained an average of 3.12 and after the
installation of HFNC there was an increase in the average
ROX index of 4.48. In this study, the successful
installation of HFNC was 61 people out of a total of 70
samples.
Discussion: The ROX index can be helpful in identifying
subjects who are more at risk for poorer outcomes.
Therefore, early invasive mechanical ventilation can be
used to prevent worse outcomes in patients with COVID19-associated AHRF.
Keywords :
ROX index, high flow nasal canule, NIV, ventilator, COVID-19
